Evidence map›Paper›PMID 33467922›Full record

ReviewExpert opinion on drug discovery2021

Drug discovery through the isolation of natural products from Burkholderia.

Adam Foxfire, Andrew Riley Buhrow, Ravi S Orugunty, Leif Smith

Open access · greenAbstract readReview
In one paragraph

Review in Expert opinion on drug discovery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biological control ofFrontiers in microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. AApplied and environmental microbiology · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adam FoxfireDepartment of Biology, Texas A&M University, College Station, USA.
Andrew Riley BuhrowDepartment of Biology, Texas A&M University, College Station, USA.
Ravi S OruguntyAntimicrobial Division, Sano Chemicals Inc, Bryan, USA.
Leif SmithDepartment of Biology, Texas A&M University, College Station, USA.
Texas A&M University · US

Funding

Preclinical Development of OCF001 for Treatment of Yeast InfectionsR42AI131792 · NIAID · SANO CHEMICALS, INC · PI SMITH, JAMES LEIF · 2019 to 2021
$2.9M
Optimization of the Production and Isolation of the Novel Antifungal OccidiofunginR41AI122441 · NIAID · SANO CHEMICALS, INC · PI SMITH, JAMES LEIF · 2016 to 2017
$530k
Functional Characterization of the Site Specific Residues in Mutacin 1140R15AI079897 · NIAID · MISSISSIPPI STATE UNIVERSITY · PI SMITH, JAMES LEIF · 2008 to 2009
$245k
A Novel Therapeutic Agent for the Treatment of Gram-positive InfectionsR41AI149803 · NIAID · SANO CHEMICALS, INC · PI SMITH, JAMES LEIF · 2020 to 2020
$233k
Lead Compound Discovery from Engineered Analogs of OccidiofunginR41AI131792 · NIAID · SANO CHEMICALS, INC · PI SMITH, JAMES LEIF · 2017 to 2017
$225k
NIAID NIH HHS R15 AI079897NIAID NIH HHS R41 AI122441NIAID NIH HHS R41 AI131792NIAID NIH HHS R41 AI149803NIAID NIH HHS R42 AI131792
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsBurkholderiaBurkholderia InfectionsBurkholderia pseudomalleiDrug DiscoveryHumansBiological Productsantibioticsantifungalsantimicrobial ResistanceBurkholderiacyclic lipopeptidesdrug Discoverynatural Productsoccidiofunginornibactinsiderophores

Identifiers

PMID33467922
PMCPMC9844120
OpenAlexW3125227012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.